Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
156.00
164.00
143.00
123.00
142.00
79.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
156.00
164.00
143.00
123.00
142.00
79.00
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
-5.00
0.00
0.00
-2.00
0.00
Raw Materials Consumed
75.00
80.00
70.00
59.00
67.00
40.00
Power & Fuel Cost
9.00
9.00
8.00
6.00
4.00
3.00
Employee Cost
26.00
23.00
18.00
14.00
14.00
12.00
Operating Expenses
7.00
8.00
6.00
5.00
4.00
2.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
8.00
6.00
6.00
4.00
6.00
4.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
1.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
131.00
129.00
114.00
92.00
96.00
65.00
Operating Profit (PBDIT) excl Other Income
25.00
34.00
29.00
31.00
46.00
13.00
Other Income
3.00
1.00
1.00
0.00
0.00
0.00
Operating Profit (PBDIT)
29.00
36.00
31.00
32.00
46.00
13.00
Interest
0.00
1.00
0.00
0.00
1.00
2.00
Profit before Depriciation and Tax
28.00
34.00
30.00
31.00
45.00
11.00
Depreciation
4.00
3.00
2.00
2.00
2.00
1.00
Profit Before Taxation & Exceptional Items
24.00
31.00
28.00
28.00
43.00
9.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
24.00
31.00
28.00
28.00
42.00
10.00
Provision for Tax
6.00
7.00
7.00
7.00
11.00
2.00
Profit After Tax
18.00
23.00
21.00
21.00
31.00
7.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
116.00
92.00
69.00
48.00
22.00
15.00
Profit Available for appropriations
137.00
117.00
94.00
70.00
52.00
22.00
Appropriations
137.00
117.00
94.00
70.00
52.00
22.00
Equity Dividend (%)
20.00%
20.00%
18.00%
15.00%
15.00%
10.00%
Earnings Per Share
26.06
30.07
30.06
26.24
36.71
8.55
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -4.65% vs 13.94% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -25.83% vs 16.13% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -31.47% vs 56.86% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -22.79% vs 12.55% in Mar 2024
Compare Profit and Loss Results of Titan Biotech
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
156.00
1,078.00
-922.00
-85.53%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
156.00
1,078.00
-922.00
-85.53%
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
-15.00
13.00
86.67%
Raw Materials Consumed
75.00
747.00
-672.00
-89.96%
Power & Fuel Cost
9.00
59.00
-50.00
-84.75%
Employee Cost
26.00
55.00
-29.00
-52.73%
Operating Expenses
7.00
40.00
-33.00
-82.50%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
8.00
63.00
-55.00
-87.30%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
2.00
-1.00
-50.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
131.00
977.00
-846.00
-86.59%
Operating Profit (PBDIT) excl Other Income
25.00
101.00
-76.00
-75.25%
Other Income
3.00
15.00
-12.00
-80.00%
Operating Profit (PBDIT)
29.00
116.00
-87.00
-75.00%
Interest
0.00
22.00
-22.00
-100.00%
Profit before Depriciation and Tax
28.00
93.00
-65.00
-69.89%
Depreciation
4.00
17.00
-13.00
-76.47%
Profit Before Taxation & Exceptional Items
24.00
76.00
-52.00
-68.42%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
24.00
76.00
-52.00
-68.42%
Provision for Tax
6.00
21.00
-15.00
-71.43%
Profit After Tax
18.00
55.00
-37.00
-67.27%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
116.00
195.00
-79.00
-40.51%
Profit Available for appropriations
137.00
251.00
-114.00
-45.42%
Appropriations
137.00
251.00
-114.00
-45.42%
Equity Dividend (%)
20%
10%
10.00
Earnings Per Share
26.06
7.7
18.36
238.44%
Profit And Loss - Net Sales
Net Sales 156.45 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -4.65% vs 13.94% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 25.43 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -25.83% vs 16.13% in Mar 2024
Profit And Loss - Interest
Interest 0.80 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -31.47% vs 56.86% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 18.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -22.79% vs 12.55% in Mar 2024






